Cantargia announces intention of a directed share issue
STOCKHOLM, Dec. 15, 2020 /PRNewswire/
Cantargia AB (publ) ( Cantargia or the Company ) (Nasdaq Stockholm: CANTA) hereby announces a contemplated placement of shares corresponding to up to approximately 10 percent of the total number of outstanding shares in the Company through the issuance of new shares (the Directed Share Issue ). The Directed Share issue will be directed to Swedish and international institutional investors. Cantargia has engaged Carnegie Investment Bank AB (publ), Kempen & Co and Oppenheimer & Co. Inc. to act as Joint Bookrunners (together the Joint Bookrunners ) and to investigate the conditions for a placement of new shares through an accelerated book building procedure.
OncoZenge raises MSEK 10 ahead of spin-off and separate listing pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ OncoZenge AB (publ) ("OncoZenge"), Moberg Pharma AB (publ) s subsidiary, has today resolved on a directed share issue in accordance with the.